AZO vs MAZE · P/E 21, rev $18.94B vs $525.3M cap
AutoZone Inc (AZO) versus Maze Therapeutics, Inc. Common Stock (MAZE) — a side-by-side from cached financials, not a winner call.
AutoZone Inc (AZO) is a auto parts company listed on NYSE.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Latest reported AZO revenue for 2025-08-30 was $18.94B. Net income was $2.50B. Revenue was up 2.4% from 2024-08-31 to 2025-08-30. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
Latest reported MAZE revenue for 2025-06-30 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-09-30 to 2025-06-30. MAZE currently screens at market cap $525.3M.
AZO currently screens at market cap $50.08B and trailing P/E 21.0. MAZE currently screens at market cap $525.3M.
Not investment advice. Open the AZO and MAZE stock pages for the full models.
Not investment advice.